NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/24/2025
Back to search
Official data from USPTO
VENTRIBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
06/24/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/17/2024
Registration date
06/24/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/24/2025
Last transaction
06/24/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Bree, BE
Examiner
HSU, FONG
Law office
O20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
VENTRIBIO, besloten vennootschap
Representatives
Clifford D. Hyra Fresh IP PLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of gastrointestinal conditionsmusculo-skeletal conditions and joint diseases; vaccines; dietary supplements; nutritional supplements; dietetic preparations adapted for medical usegastro-intestinal treatment preparations; food supplements for human consumption in the form of tablets and capsules; pharmaceutical products for human use in the form of tablets and capsules for the prevention and treatment of gastrointestinal conditionsmusculo-skeletal conditions and joint diseases; probiotic supplements; prebiotic supplements; food supplements for human consumption; nutraceutical preparations for therapeutic or medical purposes for the prevention and treatment of gastrointestinal conditionsmusculo-skeletal conditions and joint diseases; stem cells for medical purposes; pharmaceutical preparations containing stem cells for the treatment of genetic diseases in the nature of single-gene disordersimmunological diseases and cancer; cell growth media for growing cells for medical use; cells for medical or clinical use; personalized cell therapiesstem cells for medical use; pharmaceutical preparations and substances for the treatment of genetic diseases and immunological diseases; pharmaceutical preparations and substances for applications in tissue engineering and regenerative medicine; blood plasma; antibacterial gels; body gels for pharmaceutical use for the treatment of burnsacneallergic reactionseczemadermatitispsoriasisviralbacterial and fungal skin infections
Publications
History of USPTO decisions and trademark events.
13 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/24/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/06/2025
PUBO
PUBLISHED FOR OPPOSITION
05/06/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/30/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/07/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/31/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/31/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/31/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/31/2025
DOCK
ASSIGNED TO EXAMINER
03/24/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/17/2024
NWAP
NEW APPLICATION ENTERED
10/17/2024
Continuous trademark protection
Get notified about every new filing that threatens VENTRIBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.